Abivax
Abivax is a clinical-stage biotechnology company founded in 2013 in Paris, developing oral microRNA-based therapeutics for chronic inflammatory diseases, led by obefazimod in ulcerative colitis.
0 jobs
Jobs
No jobs match — try clearing a filter.